The stock analysts valuation of $12 (Linda Ong from bell potter ) was to be upgraded on condition that the 48 week data from the Phase 11 liver trial was as good as the 30 week data.
look out for broker upgrades and buy recommendations next week.
PGL Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
